Aethlon Medical AEMD

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
-$0.01 (-3.24%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of Aethlon Medical (AEMD)
Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Key Insights

Critical company metrics and information

  • Latest Closing Price

    $0.4366

  • Market Cap

    $6.31 Million

  • Price-Earnings Ratio

    -0.15

  • Total Outstanding Shares

    14.46 Million Shares

  • Total Employees

    14

  • Dividend

    No dividend

  • IPO Date

    March 4, 1999

  • SIC Description

    Surgical & Medical Instruments & Apparatus

  • Primary Exchange

    NASDAQ

  • Type

    Common Stock

  • Headquarters

    11555 sorrento valley road, suite 203, San diego, CA, 92121

  • Homepage

    https://www.aethlonmedical.com

Historical Stock Splits

If you bought 7,500 shares of AEMD before April 14, 2015, you'd have 1 share today.
Execution DateSplit Amount
October 5, 20231-for-10 (Reverse Split)
October 15, 20191-for-15 (Reverse Split)
April 14, 20151-for-50 (Reverse Split)

Cash Flow Statement

October 1, 2023 to September 30, 2024
MetricValue
Net Cash Flow From Operating Activities, Continuing$-8.91 Million
Net Cash Flow From Operating Activities$-8.91 Million
Net Cash Flow$-4.74 Million
Net Cash Flow From Investing Activities$-1.43 Million
Net Cash Flow, Continuing$-4.74 Million
Net Cash Flow From Financing Activities, Continuing$5.60 Million

Income Statement

October 1, 2023 to September 30, 2024
MetricValue
Basic Earnings Per Share$-2.82
Preferred Stock Dividends And Other Adjustments$0
Diluted Average Shares$23.95 Million
Revenues$0
Income/Loss From Continuing Operations Before Tax$-11.27 Million
Operating Expenses$11.58 Million

Comprehensive Income

October 1, 2023 to September 30, 2024
MetricValue
Comprehensive Income/Loss Attributable To Parent$-11.27 Million
Comprehensive Income/Loss$-11.27 Million
Comprehensive Income/Loss Attributable To Noncontrolling Interest$0
Other Comprehensive Income/Loss$3,770

Balance Sheet

October 1, 2023 to September 30, 2024
MetricValue
Other Current Liabilities$1.41 Million
Accounts Payable$922,888
Current Assets$7.14 Million
Fixed Assets$843,617
Assets$8.85 Million
Equity Attributable To Parent$6.02 Million

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends

Recent Headlines From The Web

Latest news, press releases, and media coverage about AEMD from trusted financial sources
    All TickersEarnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

    ⓒ 2025 Financhle. All Rights Reserved.